Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance at the beginning at Dec. 31, 2020 $ (3,496,499) $ 14 $ 2,044,362 $ (5,540,875)
Balance at the beginning (in shares) at Dec. 31, 2020   142,369    
Exchange of common stock of Marpai Health, Inc. (see Note 1) (14) $ (14)    
Exchange of common stock of Marpai Health, Inc. (in shares)   (142,369)    
Issuance of common stock of Marpai, Inc. (see Note 1) 17,351,935 $ 1,115 17,350,820  
Issuance of common stock of Marpai, Inc. (in shares)   11,147,302    
Issuance of warrants to shareholder in exchange for cash 53,333   53,333  
Stock options exercised 49 $ 2 47  
Stock options exercised (in shares)   22,523    
Share-based compensation 962,143   962,143  
Net loss (10,256,167)     (10,256,167)
Balance at the end at Sep. 30, 2021 4,614,780 $ 1,117 20,410,705 (15,797,042)
Balance at the end (in shares) at Sep. 30, 2021   11,169,825    
Balance at the beginning at Jun. 30, 2021 9,151,173 $ 1,115 20,154,521 (11,004,463)
Balance at the beginning (in shares) at Jun. 30, 2021   11,147,301    
Stock options exercised 49 $ 2 47  
Stock options exercised (in shares)   22,524    
Share-based compensation 256,137   256,137  
Net loss (4,792,579)     (4,792,579)
Balance at the end at Sep. 30, 2021 4,614,780 $ 1,117 20,410,705 (15,797,042)
Balance at the end (in shares) at Sep. 30, 2021   11,169,825    
Balance at the beginning at Dec. 31, 2021 $ 29,708,412 $ 2,030 51,232,092 (21,525,710)
Balance at the beginning (in shares) at Dec. 31, 2021 20,299,727 20,299,727    
Share-based compensation $ 2,182,696   2,182,696  
Issuance of stock upon vesting of restricted stock units 61 $ 61    
Issuance of stock upon vesting of restricted stock units (in shares)   608,174    
Shares issued to vendors in exchange for services $ 30,902 $ 3 30,899  
Shares issued to vendors in exchange for services (in shares) 22,500 30,000    
Net loss $ (17,934,306)     (17,934,306)
Balance at the end at Sep. 30, 2022 $ 13,987,765 $ 2,094 53,445,687 (39,460,016)
Balance at the end (in shares) at Sep. 30, 2022 20,937,901 20,937,901    
Balance at the beginning at Jun. 30, 2022 $ 19,070,499 $ 2,068 52,748,587 (33,680,156)
Balance at the beginning (in shares) at Jun. 30, 2022   20,682,843    
Share-based compensation 689,375   689,375  
Issuance of stock upon vesting of restricted stock units 25 $ 25    
Issuance of stock upon vesting of restricted stock units (in shares)   247,558    
Shares issued to vendors in exchange for services 7,726 $ 1 7,725  
Shares issued to vendors in exchange for services (in shares)   7,500    
Net loss (5,779,860)     (5,779,860)
Balance at the end at Sep. 30, 2022 $ 13,987,765 $ 2,094 $ 53,445,687 $ (39,460,016)
Balance at the end (in shares) at Sep. 30, 2022 20,937,901 20,937,901